EP2844346 - Bibliographic data
COMPOSITIONS PHARMACEUTIQUES POUR TRAITEMENT COMBINÉ
| Last update | 25/07/2025 |
|---|---|
| Legal status | Brevet déchu |
| Origin | Euro-PCT |
| (73) Holder |
Prilenia Neurotherapeutics Ltd. 10 HaMenofim Street
4672561 Herzliya
Israël
|
|---|---|
| (72) Inventors |
Ross WATERS Solbanksgatan 22
S-413 19 Göteborg
Suède
Eva WATERS Solbänksgatan 22
S-413 19 Göteborg
Suède
|
| (74) Agent |
Mail recipient Pearl Cohen Zedek Latzer Baratz UK LLP The Gridiron Building
One Pancras Square
London N1C 4AG
Royaume-Uni
|
| (21) Request number | EP13772325.0 |
|---|---|
| (22) Request date | 03/04/2013 |
| (11) Publication number | EP2844346 |
|---|---|
| Publication date | 01/01/2020 |
| (54) Title of the invention | COMPOSITIONS PHARMACEUTIQUES POUR TRAITEMENT COMBINÉ |
|---|---|
| (51) International classification | A61K 31/451, A61K 31/4745, A61P 25/14 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 201261620203 P |
|---|---|
| Initial application | None |
| Divisional application | None |
| Expected annuity |
Annuity: 8 -
Amount: 140 € -
Due date 30/04/2020
Surtax: 8 - Amount: 28 € - Due date 03/11/2020 |
|---|---|
| Last annuity | None |
| Publication | None |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 01/01/2020 Entrée en période de grâce du brevet d'invention - Legal date 01/05/2020 Déchéance du brevet d'invention après période de grâce - Legal date 30/04/2020 |